The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration

Biomaterials

Volumn 33, Issue 32, 2012, Pages 8062-8074

  Yu, Jian ^a,c   Wang, Aijun ^a,d   Tang, Zhenyu ^a,b   Henry, Jeffrey ^a,b   Li Ping Lee, Benjamin ^a,b   Zhu, Yiqian ^a,b   Yuan, Failei ^a   Huang, Fengping ^c   Li, Song ^a,b  

^a University of California at Berkeley   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

In situ tissue engineering; Progenitor cells; SDF 1 ; Vascular grafts

Indexed keywords

BIOACTIVE MATERIAL; BROAD APPLICATION; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIALIZATION; FAILURE RATE; FLOW CONDITION; FUNCTIONAL PERFORMANCE; IN-SITU; IN-VITRO; IN-VIVO; MICROFIBROUS; PROGENITOR CELL; REGENERATIVE MEDICINE; SMOOTH MUSCLE CELLS; SMOOTH MUSCLES; SYNTHETIC VASCULAR GRAFT; TISSUE-ENGINEERED BLOOD VESSELS; VASCULAR GRAFTS; VASCULAR TISSUE ENGINEERING;

BLOOD VESSELS; COATINGS; ENDOTHELIAL CELLS; GRAFTS; POLYSACCHARIDES; TISSUE ENGINEERING;

CYTOLOGY;

HEPARIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BLOOD VESSEL GRAFT; BLOOD VESSEL SHUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; GRAFT PATENCY; MALE; MATERIAL COATING; MATERIALS TESTING; NONHUMAN; PRIORITY JOURNAL; RAT; REGENERATIVE MEDICINE; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; TISSUE REGENERATION; YOUNG MODULUS;

ANIMALS; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINE CXCL12; COATED MATERIALS, BIOCOMPATIBLE; ELASTIC MODULUS; ENDOTHELIAL CELLS; HEPARIN; MALE; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; VASCULAR GRAFTING; VASCULAR PATENCY;

RATTUS;

EID: 84865545675     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.07.042     Document Type: Article

References (43)

1. Cleary M.A., Geiger E., Grady C., Best C., Naito Y., Breuer C. Vascular tissue engineering: the next generation. Trends Mol Med 2012, 18:394-404.
2. L'Heureux N., Dusserre N., Konig G., Victor B., Keire P., Wight T.N., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006, 12:361-365.
3. Isenberg B.C., Williams C., Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ Res 2006, 98:25-35.
4. Nerem R.M., Seliktar D. Vascular tissue engineering. Annu Rev Biomed Eng 2001, 3:225-243.
5. Li S., Henry J.J. Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng 2011, 13:451-475.
6. Dahl S.L., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3:68ra9.
7. Hashi C.K., Zhu Y., Yang G.Y., Young W.L., Hsiao B.S., Wang K., et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A 2007, 104:11915-11920.
8. Gong Z., Niklason L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 2008, 22:1635-1648.
9. Roh J.D., Sawh-Martinez R., Brennan M.P., Jay S.M., Devine L., Rao D.A., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A 2010, 107:4669-4674.
10. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005, 129:1330-1338.
11. Olausson M., Patil P.B., Kuna V.K., Chougule P., Hernandez N., Methe K., et al. Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study. Lancet 2012, 380:230-237.
12. Luttun A., Carmeliet G., Carmeliet P. Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 2002, 12:88-96.
13. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
14. Hirschi K.K., Goodell M.A. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther 2002, 9:648-652.
15. Tintut Y., Alfonso Z., Saini T., Radcliff K., Watson K., Bostrom K., et al. Multilineage potential of cells from the artery wall. Circulation 2003, 108:2505-2510.
16. Hu Y., Zhang Z., Torsney E., Afzal A.R., Davison F., Metzler B., et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004, 113:1258-1265.
17. Sainz J., Al Haj Zen A., Caligiuri G., Demerens C., Urbain D., Lemitre M., et al. Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 2006, 26:281-286.
18. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
19. Boland E.D., Matthews J.A., Pawlowski K.J., Simpson D.G., Wnek G.E., Bowlin G.L. Electrospinning collagen and elastin: preliminary vascular tissue engineering. Front Biosci 2004, 9:1422-1432.
20. Stitzel J., Liu J., Lee S.J., Komura M., Berry J., Soker S., et al. Controlled fabrication of a biological vascular substitute. Biomaterials 2006, 27:1088-1094.
21. Soffer L., Wang X., Zhang X., Kluge J., Dorfmann L., Kaplan D.L., et al. Silk-based electrospun tubular scaffolds for tissue-engineered vascular grafts. J Biomater Sci Polym Ed 2008, 19:653-664.
22. Nieponice A., Soletti L., Guan J., Deasy B.M., Huard J., Wagner W.R., et al. Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials 2008, 29:825-833.
23. Hashi C.K., Derugin N., Janairo R.R., Lee R., Schultz D., Lotz J., et al. Antithrombogenic modification of small-diameter microfibrous vascular grafts. Arterioscler Thromb Vasc Biol 2010, 30:1621-1627.
24. Patel S., Kurpinski K., Quigley R., Gao H., Hsiao B.S., Poo M.M., et al. Bioactive nanofibers: synergistic effects of nanotopography and chemical signaling on cell guidance. Nano Lett 2007, 7:2122-2128.
25. Dorigo W., Pulli R., Piffaretti G., Castelli P., Griselli F., Dorrucci V., et al. Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses. J Cardiovasc Surg (Torino) 2012, 53:187-194.
26. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
27. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999, 18:3964-3972.
28. Landmesser U., Engberding N., Bahlmann F.H., Schaefer A., Wiencke A., Heineke A., et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 2004, 110:1933-1939.
29. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104:3472-3482.
30. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
31. Kurpinski K., Lam H., Chu J.L., Wang A.J., Kim A., Tsay E., et al. Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 2010, 28:734-742.
32. Deutsch M., Meinhart J., Zilla P., Howanietz N., Gorlitzer M., Froeschl A., et al. Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts. J Vasc Surg 2009, 49:352-362. discussion 62.
33. Koch S., Flanagan T.C., Sachweh J.S., Tanios F., Schnoering H., Deichmann T., et al. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials 2010, 31:4731-4739.
34. Amara A., Lorthioir O., Valenzuela A., Magerus A., Thelen M., Montes M., et al. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem 1999, 274:23916-23925.
35. Murphy J.W., Cho Y., Sachpatzidis A., Fan C., Hodsdon M.E., Lolis E. Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem 2007, 282:10018-10027.
36. Sadir R., Baleux F., Grosdidier A., Imberty A., Lortat-Jacob H. Characterization of the stromal cell-derived factor-1alpha-heparin complex. J Biol Chem 2001, 276:8288-8296.
37. Sadir R., Imberty A., Baleux F., Lortat-Jacob H. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 2004, 279:43854-43860.
38. De Visscher G., Mesure L., Meuris B., Ivanova A., Flameng W. Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1alpha. Acta Biomater 2012, 8:1330-1338.
39. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
40. Salvucci O., Yao L., Villalba S., Sajewicz A., Pittaluga S., Tosato G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002, 99:2703-2711.
41. Tang Z., Wang A., Yuan F., Yan Z., Liu B., Chu J.S., et al. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun 2012, 3:875.
42. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Jung S., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
43. Zilla P., Bezuidenhout D., Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 2007, 28:5009-5027.